日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A survey of practices for the use of electronic health records to support research recruitment

一项关于利用电子健康记录支持研究招募的实践调查

Obeid, Jihad S; Beskow, Laura M; Rape, Marie; Gouripeddi, Ramkiran; Black, R Anthony; Cimino, James J; Embi, Peter J; Weng, Chunhua; Marnocha, Rebecca; Buse, John B

A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

一项针对晚期实体瘤患者(包括广泛期小细胞肺癌患者)的AT-101联合顺铂和依托泊苷的I期研究

Schelman, William R; Mohammed, Tabraiz A; Traynor, Anne M; Kolesar, Jill M; Marnocha, Rebecca M; Eickhoff, Jens; Keppen, Michael; Alberti, Dona B; Wilding, George; Takebe, Naoko; Liu, Glenn

A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors

一项针对晚期实体瘤患者的间歇给药伏立诺他联合硼替佐米的I期研究

Deming, Dustin A; Ninan, Jacob; Bailey, Howard H; Kolesar, Jill M; Eickhoff, Jens; Reid, Joel M; Ames, Matthew M; McGovern, Renee M; Alberti, Dona; Marnocha, Rebecca; Espinoza-Delgado, Igor; Wright, John; Wilding, George; Schelman, William R

A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies

一项针对晚期恶性肿瘤患者的伏立诺他联合硼替佐米治疗的I期研究

Schelman, William R; Traynor, Anne M; Holen, Kyle D; Kolesar, Jill M; Attia, Steven; Hoang, Tien; Eickhoff, Jens; Jiang, Zhisheng; Alberti, Dona; Marnocha, Rebecca; Reid, Joel M; Ames, Matthew M; McGovern, Renee M; Espinoza-Delgado, Igor; Wright, John J; Wilding, George; Bailey, Howard H

Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.

使用 FLT PET/CT 对接受舒尼替尼苹果酸盐治疗的肾细胞癌和其他实体恶性肿瘤患者进行药效学研究

Liu Glenn, Jeraj Robert, Vanderhoek Matt, Perlman Scott, Kolesar Jill, Harrison Michael, Simoncic Urban, Eickhoff Jens, Carmichael Lakeesha, Chao Bo, Marnocha Rebecca, Ivy Percy, Wilding George

The maximum tolerated dose and biologic effects of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) in combination with irinotecan for patients with refractory solid tumors

3-氨基吡啶-2-甲醛硫代氨基脲(3-AP)联合伊立替康治疗难治性实体瘤患者的最大耐受剂量和生物学效应

Choi, Brian S; Alberti, Dona B; Schelman, William R; Kolesar, Jill M; Thomas, James P; Marnocha, Rebecca; Eickhoff, Jens C; Ivy, S Percy; Wilding, George; Holen, Kyle D

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer

编码前列腺酸性磷酸酶的DNA疫苗在D0期前列腺癌患者中的安全性和免疫学疗效

McNeel, Douglas G; Dunphy, Edward J; Davies, James G; Frye, Thomas P; Johnson, Laura E; Staab, Mary Jane; Horvath, Dorothea L; Straus, Jane; Alberti, Dona; Marnocha, Rebecca; Liu, Glenn; Eickhoff, Jens C; Wilding, George